| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,297,800 | 1,427,600 | 3,200,800 | 3,418,300 | | Cost of Revenue | 1,688,000 | 689,000 | 2,971,000 | 4,081,800 | | | Gross Profit | (390,200) | 738,600 | 229,800 | (663,500) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (543,400) | 589,000 | 26,900 | (756,200) | | Non Recurring | 2,400 | 19,100 | 291,100 |
-
| | Others | 57,500 | 57,600 | 56,900 | 57,600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 93,300 | 72,900 | (145,100) | 35,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 25,900 | 20,800 | 21,200 | 73,500 | | Earnings Before Interest And Taxes | 119,200 | 93,700 | (123,900) | 58,000 | | Interest Expense | 41,700 | 40,000 | 42,700 | 47,200 | | Income Before Tax | 77,500 | 53,700 | (166,600) | 10,800 | | Income Tax Expense | 28,000 | 18,500 | 12,800 | (11,000) | | Minority Interest |
-
|
-
|
-
| 100 | | | | Net Income From Continuing Ops | 49,500 | 35,200 | (179,400) | 21,800 | | | Non-recurring Events | | Discontinued Operations | 2,300 | 300 |
-
| 4,600 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 51,800 | 35,500 | (179,400) | 26,400 | | Preferred Stock And Other Adjustments | (700) | (800) | (800) | (800) | | | Net Income Applicable To Common Shares | $51,100 | $34,700 | ($180,200) | $25,600 |
|
0.01% Nasdaq 
0.22%
Income Statement
